Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik.

Slides:

Advertisements

Similar presentations

Retrograde open mesenteric stenting for acute mesenteric ischemia

Advertisements

Dominique B. Buck, MD, Thomas Curran, MD, John C

Willem E. Hellings, MD, Gerard Pasterkamp, MD, PhD, Bart A. N

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Remote iliac artery endarterectomy: seven-year results of a less invasive technique for iliac artery occlusive disease Luuk Smeets, MD, Gerrit-Jan de.

Comparison of covered stents versus bare metal stents for treatment of chronic atherosclerotic mesenteric arterial disease Gustavo S. Oderich, MD, Luke.

Freedom from secondary interventions to treat stenotic disease after percutaneous transluminal angioplasty of infrarenal aorta: long-term results J.P.P.M.

A percutaneous arterial closure protocol can decrease complications after endovascular interventions in vascular surgery patients Philip P. Goodney,

Results of endovascular repair of infrarenal aortic aneurysms using the Endurant stent graft Herman J.A. Zandvoort, MD, PhD, Frederico Bastos Gonçalves,

Linda Le, MD, William Terral, MD, Nicolas Zea, MD, Hernan A

Ali F. AbuRahma, MD, J. David Hayes, MD, Sarah K

Tim J. van Oostenbrugge, MD, Jean-Paul P. M

Boudewijn L. Reichmann, MD, Jorinde H. H. van Laanen, MD, Jean-Paul P

Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage Caren Randon, MD, Bart Jacobs, MD, Frederik.

Balloon angioplasty versus Viabahn stent graft for treatment of failing or thrombosed prosthetic hemodialysis grafts Thomas Vesely, MD, William DaVanzo,

Long-term safety of cilostazol in patients with peripheral artery disease: The CASTLE study (Cilostazol: A Study in Long-term Effects) William R. Hiatt,

Todd R. Vogel, MD, MPH, Viktor Y. Dombrovskiy, MD, PhD, MPH, Paul B

Tommaso Lupattelli, MD, Giovanni Nano, MD, Luigi Inglese, MD

The effect of alcohol on atherosclerotic plaque composition and cardiovascular events in patients with arterial occlusive disease Suzanne S. Gisbertz,

Blake A. Hamby, MD, Daniel E. Ramirez, MD, George E

Mesenteric stenting for chronic mesenteric ischemia

Vascular interventions in head and neck cancer patients as a marker of poor survival Emilia Krol, MD, Colin T. Brandt, MD, Juliet Blakeslee-Carter, BS,

Changing pattern of surgical revascularization for critical limb ischemia over 12 years: Endovascular vs open bypass surgery Toshifumi Kudo, MD, PhD,

Low-molecular-weight heparin for prevention of restenosis after femoropopliteal percutaneous transluminal angioplasty: A randomized controlled trial

Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease Mare M.A. Lensvelt, MD, Wilbert M. Fritschy,

Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: A comparative experience Marvin D. Atkins, MD, Christopher J.

Histologic atherosclerotic plaque characteristics are associated with restenosis rates after endarterectomy of the common and superficial femoral arteries

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

Open versus endovascular revascularization for chronic mesenteric ischemia: Risk- stratified outcomes Gustavo S. Oderich, MD, Thomas C. Bower, MD, Timothy.

Outcomes of reinterventions after subintimal angioplasty

Chetan P. Huded, MD, Philip P. Goodney, MD, Richard J

Retrograde open mesenteric stenting for acute mesenteric ischemia

Infrainguinal cutting balloon angioplasty in de novo arterial lesions

Endovascular treatment of atherosclerotic popliteal artery disease based on dynamic angiography findings Chaoyi Cui, MD, PhD, Xintian Huang, MD, Xiaobing.

A comparison of percutaneous transluminal angioplasty versus amputation for critical limb ischemia in patients unsuitable for open surgery Spence M.

Marc L. Schermerhorn, MD, Kristina A. Giles, MD, Allen D

Outcomes of renal artery angioplasty and stenting using low-profile systems Brian W. Nolan, MD, Marc L. Schermerhorn, MD, Erin Rowell, MD, Richard J.

Revascularization of acute mesenteric ischemia after creation of a dedicated multidisciplinary center Arnaud Roussel, MD, Yves Castier, MD, PhD, Alexandre.

Sadaf S. Ahanchi, MD, Christopher L. Stout, MD, Tyler J

Andre Biuckians, MD, MPH, Eric C. Scott, MD, George H

Bypass for chronic ischemia of the upper extremity: Results in 20 patients Kakra Hughes, MD, Allen Hamdan, MD, Marc Schermerhorn, MD, Anthony Giordano,

Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients Andrew M. Bakken, MD, Clinton D. Protack,

Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia Kevin E. Todd, BS, Sadaf S. Ahanchi, MD, Christian.

Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia Panagiotis Kougias, MD, Donald Lau, BS,

Nitinol stenting improves primary patency of the superficial femoral artery after percutaneous transluminal angioplasty in hemodialysis patients: A propensity-matched.

Ten-year experience with renal artery in-stent stenosis

The durability of endovascular repair of para-anastomotic aneurysms after previous open aortic reconstruction Jan A. Ten Bosch, MD, Evert J. Waasdorp,

Toshifumi Kudo, MD, PhD, Fiona A. Chandra, Samuel S. Ahn, MD

Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy John.

Paclitaxel-coated versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis Klaus Linni, MD, Ara Ugurluoglu, MD, Manuela.

Wei Zhou, MD, Peter H. Lin, MD, Ruth L. Bush, MD, Eric K

Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: Long-term results Jean-Paul P.M. de Vries,

Thrombotic mesenteric ischemia due to aortic dissection

Manish Mehta, MD, MPH, Yi Zhou, MD, Philip S. K

A personal experience with factors influencing survival after elective open repair of infrarenal aortic aneurysms Norman R. Hertzer, MD, Edward J. Mascha,

Optimizing infrainguinal arm vein bypass patency with duplex ultrasound surveillance and endovascular therapy Paul A. Armstrong, DO, Dennis F. Bandyk,

Gregory C. Schmieder, MD, Megan Carroll, BA, BS, Jean M. Panneton, MD

Christopher J. Abularrage, MD, Mark F. Conrad, MD, MMSc, Lauren A

Long-term outcomes of patients undergoing endovascular infrainguinal interventions with single-vessel peroneal artery runoff Christopher J. Abularrage,

High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty

Efficacious use of nitinol stents in the femoral and popliteal arteries Todd R Vogel, MD, Larry E Shindelman, MD, Gary B Nackman, MD, Alan M Graham, MD

FT04. “The Vein Is Screwed” Proof of Concept of the VeinScrew: A New Percutaneous Venous Closure Device Doeke Boersma, MD, Frans Moll, MD, PhD, Gert Jan.

One-year multicenter results of 100 abdominal aortic aneurysm patients treated with the Endurant stent graft Jasper W. van Keulen, MD, Jean-Paul P.M.

Differences in anatomy and outcomes in patients treated with open mesenteric revascularization before and after the endovascular era Evan J. Ryer, MD,

The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: A 10-year experience Toshifumi Kudo, MD, PhD,

Incidence and treatment results of Endurant endograft occlusion

Everolimus Drug-Eluting Stents Are Associated With Improved Outcomes for the Treatment of Infrainguinal Bypass Graft Stenoses Caitlin W. Hicks, MD, MS,

Renin-angiotensin-aldosterone-system inhibition is safe in the preoperative period surrounding carotid endarterectomy Andrea M. Steely, MD, Peter W.

Scott M. Surowiec, MD, Mark G. Davies, MD, PhD, Shirley W

Paul Berger, MD, Dennis de Bie, MaNP, Frans L

Presentation transcript:

Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia Bram Fioole, MD, PhD, Hendrik J.M. van de Rest, MD, Joost R.M. Meijer, MD, Marc van Leersum, MD, Sebastiaan van Koeverden, MD, Frans L. Moll, MD, PhD, Jos C. van den Berg, MD, PhD, Jean-Paul P.M. de Vries, MD, PhD Journal of Vascular Surgery Volume 51, Issue 2, Pages 386-391 (February 2010) DOI: 10.1016/j.jvs.2009.08.055 Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 1 Kaplan-Meier primary (interrupted line) and assisted primary patency (continuous line) rates of 60 mesenteric arteries treated by percutaneous transluminal angioplasty. Journal of Vascular Surgery 2010 51, 386-391DOI: (10.1016/j.jvs.2009.08.055) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 2 Clinical success in 51 patients treated for chronic mesenteric ischemia (CMI) by percutaneous transluminal angioplasty and stenting (PTAS). Journal of Vascular Surgery 2010 51, 386-391DOI: (10.1016/j.jvs.2009.08.055) Copyright © 2010 Society for Vascular Surgery Terms and Conditions

Fig 3 Kaplan-Meier primary (interrupted line) and assisted primary clinical success (continuous line) rates in 51 patients with chronic mesenteric ischemia treated by percutaneous transluminal angioplasty. Journal of Vascular Surgery 2010 51, 386-391DOI: (10.1016/j.jvs.2009.08.055) Copyright © 2010 Society for Vascular Surgery Terms and Conditions